Skip to content

Bio-Techne

NASDAQ: TECH · USD

Bio-Techne financials

6 charts

Revenue

USD millions

$321.192M
Bio-Techne Revenue. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodRevenue
FY 2011 Q1$67.945M; Change unavailable vs FY 2010 Q4
FY 2011 Q2$67.708M; −0.3% vs FY 2011 Q1
FY 2011 Q3$76.271M; +12.6% vs FY 2011 Q2
FY 2011 Q4$78.038M; +2.3% vs FY 2011 Q3
FY 2012 Q1$77.596M; −0.6% vs FY 2011 Q4
FY 2012 Q2$74.662M; −3.8% vs FY 2012 Q1
FY 2012 Q3$83.621M; +12.0% vs FY 2012 Q2
FY 2012 Q4$78.681M; −5.9% vs FY 2012 Q3
FY 2013 Q1$75.025M; −4.6% vs FY 2012 Q4
FY 2013 Q2$75.083M; +0.1% vs FY 2013 Q1
FY 2013 Q3$80.992M; +7.9% vs FY 2013 Q2
FY 2013 Q4$79.475M; −1.9% vs FY 2013 Q3
FY 2014 Q1$85.668M; +7.8% vs FY 2013 Q4
FY 2014 Q2$84.017M; −1.9% vs FY 2014 Q1
FY 2014 Q3$95.555M; +13.7% vs FY 2014 Q2
FY 2014 Q4$92.523M; −3.2% vs FY 2014 Q3
FY 2015 Q1$108.477M; +17.2% vs FY 2014 Q4
FY 2015 Q2$111.948M; +3.2% vs FY 2015 Q1
FY 2015 Q3$114.158M; +2.0% vs FY 2015 Q2
FY 2015 Q4$117.663M; +3.1% vs FY 2015 Q3
FY 2016 Q1$112.381M; −4.5% vs FY 2015 Q4
FY 2016 Q2$120.907M; +7.6% vs FY 2016 Q1
FY 2016 Q3$130.973M; +8.3% vs FY 2016 Q2
FY 2016 Q4$134.762M; +2.9% vs FY 2016 Q3
FY 2017 Q1$130.581M; −3.1% vs FY 2016 Q4
FY 2017 Q2$131.807M; +0.9% vs FY 2017 Q1
FY 2017 Q3$144.037M; +9.3% vs FY 2017 Q2
FY 2017 Q4$156.578M; +8.7% vs FY 2017 Q3
FY 2018 Q1$144.613M; −7.6% vs FY 2017 Q4
FY 2018 Q2$154.153M; +6.6% vs FY 2018 Q1
FY 2018 Q3$163.973M; +6.4% vs FY 2018 Q2
FY 2018 Q4$180.254M; +9.9% vs FY 2018 Q3
FY 2019 Q1$162.97M; −9.6% vs FY 2018 Q4
FY 2019 Q2$174.51M; +7.1% vs FY 2019 Q1
FY 2019 Q3$184.861M; +5.9% vs FY 2019 Q2
FY 2019 Q4$191.664M; +3.7% vs FY 2019 Q3
FY 2020 Q1$183.243M; −4.4% vs FY 2019 Q4
FY 2020 Q2$184.934M; +0.9% vs FY 2020 Q1
FY 2020 Q3$194.68M; +5.3% vs FY 2020 Q2
FY 2020 Q4$175.834M; −9.7% vs FY 2020 Q3
FY 2021 Q1$204.199M; +16.1% vs FY 2020 Q4
FY 2021 Q2$224.253M; +9.8% vs FY 2021 Q1
FY 2021 Q3$243.552M; +8.6% vs FY 2021 Q2
FY 2021 Q4$259.028M; +6.4% vs FY 2021 Q3
FY 2022 Q1$257.719M; −0.5% vs FY 2021 Q4
FY 2022 Q2$269.276M; +4.5% vs FY 2022 Q1
FY 2022 Q3$290.376M; +7.8% vs FY 2022 Q2
FY 2022 Q4$288.228M; −0.7% vs FY 2022 Q3
FY 2023 Q1$269.655M; −6.4% vs FY 2022 Q4
FY 2023 Q2$271.581M; +0.7% vs FY 2023 Q1
FY 2023 Q3$294.146M; +8.3% vs FY 2023 Q2
FY 2023 Q4$301.32M; +2.4% vs FY 2023 Q3
FY 2024 Q1$276.935M; −8.1% vs FY 2023 Q4
FY 2024 Q2$272.598M; −1.6% vs FY 2024 Q1
FY 2024 Q3$303.428M; +11.3% vs FY 2024 Q2
FY 2024 Q4$306.099M; +0.9% vs FY 2024 Q3
FY 2025 Q1$289.458M; −5.4% vs FY 2024 Q4
FY 2025 Q2$297.031M; +2.6% vs FY 2025 Q1
FY 2025 Q3$316.181M; +6.4% vs FY 2025 Q2
FY 2025 Q4$316.964M; +0.2% vs FY 2025 Q3
FY 2026 Q1$286.555M; −9.6% vs FY 2025 Q4
FY 2026 Q2$295.877M; +3.3% vs FY 2026 Q1
FY 2026 Q3$311.415M; +5.3% vs FY 2026 Q2
FY 2026 Q4$321.192M; +3.1% vs FY 2026 Q3
Sep 30, 2010 through Sep 25, 2026

Free cash flow

USD millions

$86.936M
Bio-Techne Free cash flow. Quarterly values and changes versus the preceding comparable period. Missing values are unavailable.
PeriodFree cash flow
FY 2011 Q1$29.651M; Change unavailable vs FY 2010 Q4
FY 2011 Q2$28.72M; −3.1% vs FY 2011 Q1
FY 2011 Q3$31.794M; +10.7% vs FY 2011 Q2
FY 2011 Q4$33.399M; +5.0% vs FY 2011 Q3
FY 2012 Q1$33.336M; −0.2% vs FY 2011 Q4
FY 2012 Q2$18.237M; −45.3% vs FY 2012 Q1
FY 2012 Q3$32.876M; +80.3% vs FY 2012 Q2
FY 2012 Q4$36.28M; +10.4% vs FY 2012 Q3
FY 2013 Q1$26.748M; −26.3% vs FY 2012 Q4
FY 2013 Q2$23.067M; −13.8% vs FY 2013 Q1
FY 2013 Q3$26.652M; +15.5% vs FY 2013 Q2
FY 2013 Q4$24.641M; −7.5% vs FY 2013 Q3
FY 2014 Q1$28.774M; +16.8% vs FY 2013 Q4
FY 2014 Q2$27.675M; −3.8% vs FY 2014 Q1
FY 2014 Q3$30.673M; +10.8% vs FY 2014 Q2
FY 2014 Q4$35.819M; +16.8% vs FY 2014 Q3
FY 2015 Q1$30.813M; −14.0% vs FY 2014 Q4
FY 2015 Q2$32.584M; +5.7% vs FY 2015 Q1
FY 2015 Q3$25.852M; −20.7% vs FY 2015 Q2
FY 2015 Q4$30.205M; +16.8% vs FY 2015 Q3
FY 2016 Q1$25.712M; −14.9% vs FY 2015 Q4
FY 2016 Q2$33.652M; +30.9% vs FY 2016 Q1
FY 2016 Q3$34.301M; +1.9% vs FY 2016 Q2
FY 2016 Q4$33.307M; −2.9% vs FY 2016 Q3
FY 2017 Q1$24.06M; −27.8% vs FY 2016 Q4
FY 2017 Q2$38.327M; +59.3% vs FY 2017 Q1
FY 2017 Q3$20.923M; −45.4% vs FY 2017 Q2
FY 2017 Q4$44.959M; +114.9% vs FY 2017 Q3
FY 2018 Q1$39.423M; −12.3% vs FY 2017 Q4
FY 2018 Q2$32.847M; −16.7% vs FY 2018 Q1
FY 2018 Q3$18.142M; −44.8% vs FY 2018 Q2
FY 2018 Q4$59.021M; +225.3% vs FY 2018 Q3
FY 2019 Q1$35.258M; −40.3% vs FY 2018 Q4
FY 2019 Q2$41.959M; +19.0% vs FY 2019 Q1
FY 2019 Q3$34.737M; −17.2% vs FY 2019 Q2
FY 2019 Q4$44.254M; +27.4% vs FY 2019 Q3
FY 2020 Q1$30.014M; −32.2% vs FY 2019 Q4
FY 2020 Q2$55.854M; +86.1% vs FY 2020 Q1
FY 2020 Q3$40.187M; −28.0% vs FY 2020 Q2
FY 2020 Q4$27.418M; −31.8% vs FY 2020 Q3
FY 2021 Q1$55.071M; +100.9% vs FY 2020 Q4
FY 2021 Q2$77.824M; +41.3% vs FY 2021 Q1
FY 2021 Q3$64.264M; −17.4% vs FY 2021 Q2
FY 2021 Q4$110.704M; +72.3% vs FY 2021 Q3
FY 2022 Q1$42.364M; −61.7% vs FY 2021 Q4
FY 2022 Q2$90.825M; +114.4% vs FY 2022 Q1
FY 2022 Q3$58.028M; −36.1% vs FY 2022 Q2
FY 2022 Q4$89.147M; +53.6% vs FY 2022 Q3
FY 2023 Q1$46.525M; −47.8% vs FY 2022 Q4
FY 2023 Q2$58.275M; +25.3% vs FY 2023 Q1
FY 2023 Q3$38.787M; −33.4% vs FY 2023 Q2
FY 2023 Q4$72.562M; +87.1% vs FY 2023 Q3
FY 2024 Q1$45.791M; −36.9% vs FY 2023 Q4
FY 2024 Q2$68.252M; +49.1% vs FY 2024 Q1
FY 2024 Q3$64.545M; −5.4% vs FY 2024 Q2
FY 2024 Q4$57.516M; −10.9% vs FY 2024 Q3
FY 2025 Q1$54.717M; −4.9% vs FY 2024 Q4
FY 2025 Q2$77.525M; +41.7% vs FY 2025 Q1
FY 2025 Q3$30.997M; −60.0% vs FY 2025 Q2
FY 2025 Q4$93.311M; +201.0% vs FY 2025 Q3
FY 2026 Q1$22.222M; −76.2% vs FY 2025 Q4
FY 2026 Q2$76.49M; +244.2% vs FY 2026 Q1
FY 2026 Q3$77.575M; +1.4% vs FY 2026 Q2
FY 2026 Q4$86.936M; +12.1% vs FY 2026 Q3

Net margin

%

—
Bio-Techne Net margin. Reported fiscal history.
Fiscal period%
FY 2011 Q138.82%
FY 2011 Q239.19%
FY 2011 Q340.73%
FY 2011 Q436.3%
FY 2012 Q135.47%
FY 2012 Q234.57%
FY 2012 Q337.98%
FY 2012 Q434.62%
FY 2013 Q134.21%
FY 2013 Q233.78%
FY 2013 Q340.89%
FY 2013 Q435.75%
FY 2014 Q132.02%
FY 2014 Q229.82%
FY 2014 Q333.11%
FY 2014 Q428.99%
FY 2015 Q122.04%
FY 2015 Q229.66%
FY 2015 Q321.28%
FY 2015 Q422.38%
FY 2016 Q120.21%
FY 2016 Q221.38%
FY 2016 Q323.13%
FY 2016 Q419.02%
FY 2017 Q112.47%
FY 2017 Q24.79%
FY 2017 Q314.85%
FY 2017 Q417.63%
FY 2018 Q110.97%
FY 2018 Q231.69%
FY 2018 Q312.04%
FY 2018 Q423.13%
FY 2019 Q110.68%
FY 2019 Q210.06%
FY 2019 Q324.16%
FY 2019 Q48.59%
FY 2020 Q17.86%
FY 2020 Q264.68%
FY 2020 Q318.71%
FY 2020 Q433.47%
FY 2021 Q116.35%
FY 2021 Q220.63%
FY 2021 Q318.8%
FY 2021 Q45.78%
FY 2022 Q127.01%
FY 2022 Q229.77%
FY 2022 Q320.92%
FY 2022 Q421.35%
FY 2023 Q133.21%
FY 2023 Q218.41%
FY 2023 Q323.87%
FY 2023 Q425.05%
FY 2024 Q118.41%
FY 2024 Q210.08%
FY 2024 Q316.17%
FY 2024 Q413.26%
FY 2025 Q111.61%
FY 2025 Q211.75%
FY 2025 Q37.14%
FY 2025 Q4-5.58%
FY 2026 Q113.33%
FY 2026 Q212.85%
FY 2026 Q316.39%
FY 2026 Q4—

P/E

× · TTM · Daily

62.77×
Bio-Techne P/E. Monthly closing observations; inspect daily values with the chart arrow keys.
Close date× · TTM · DailyFinancials through
2012-08-3122.52×2012-06-30
2012-09-2823.63×2012-06-30
2012-10-3122.12×2012-06-30
2012-11-3023.68×2012-09-30
2012-12-3122.82×2012-09-30
2013-01-3123.94×2012-09-30
2013-02-2822.8×2012-12-31
2013-03-2822.75×2012-12-31
2013-04-3021.51×2012-12-31
2013-05-3122.04×2013-03-31
2013-06-2822.89×2013-03-31
2013-07-3124.43×2013-03-31
2013-08-3025.41×2013-06-30
2013-09-3026.24×2013-06-30
2013-10-3128.65×2013-06-30
2013-11-2928.04×2013-06-30
2013-12-3131.03×2013-06-30
2014-01-3129.79×2013-06-30
2014-02-2829.12×2013-06-30
2014-03-3127.98×2013-06-30
2014-04-3029.28×2013-06-30
2014-05-3028.78×2013-06-30
2014-06-3030.34×2013-06-30
2014-07-3130.59×2013-06-30
2014-08-2931.31×2013-06-30
2014-09-3030.67×2013-06-30
2014-10-3129.85×2013-06-30
2014-11-2829.59×2013-09-30
2014-12-3129.85×2013-09-30
2015-01-3030.05×2013-09-30
2015-02-2731.66×2013-12-31
2015-03-3132.56×2013-12-31
2015-04-3031.15×2013-12-31
2015-05-2934.87×2015-03-31
2015-06-3033.91×2015-03-31
2015-07-3137.67×2015-03-31
2015-08-3132.53×2015-03-31
2015-09-3032.01×2015-06-30
2015-10-3030.53×2015-06-30
2015-11-3031.95×2015-09-30
2015-12-3131.52×2015-09-30
2016-01-2928.96×2015-09-30
2016-02-2932.28×2015-12-31
2016-03-3135.55×2015-12-31
2016-04-2935.05×2015-12-31
2016-05-3138.97×2016-03-31
2016-06-3039.99×2016-03-31
2016-07-2939.87×2016-03-31
2016-08-3137.36×2016-03-31
2016-09-3038.83×2016-03-31
2016-10-3136.88×2016-03-31
2016-11-3037.36×2016-03-31
2016-12-3036.47×2016-03-31
2017-01-3136.08×2016-03-31
2017-02-2837.7×2016-03-31
2017-03-3136.05×2016-03-31
2017-04-2837.97×2016-03-31
2017-05-3139.75×2016-03-31
2017-06-3041.67×2016-03-31
2017-07-3141.1×2016-03-31
2017-08-3143.9×2016-03-31
2017-09-2959.66×2017-06-30
2017-10-3164.65×2017-06-30
2017-11-3066.49×2017-06-30
2017-12-2963.93×2017-06-30
2018-01-3169.23×2017-06-30
2018-02-2869.75×2017-06-30
2018-03-2974.53×2017-06-30
2018-04-3074.47×2017-06-30
2018-05-3174.18×2017-06-30
2018-06-2973.01×2017-06-30
2018-07-3179.27×2017-06-30
2018-08-3158.47×2018-06-30
2018-09-2862.1×2018-06-30
2018-10-3151.03×2018-06-30
2018-11-3049.09×2018-09-30
2018-12-3144.02×2018-09-30
2019-01-3153.06×2018-09-30
2019-02-2877.98×2018-12-31
2019-03-2979.85×2018-12-31
2019-04-3082.28×2018-12-31
2019-05-3163.48×2019-03-31
2019-06-2866.82×2019-03-31
2019-07-3167.36×2019-03-31
2019-08-3061.4×2019-03-31
2019-09-3062.72×2019-03-31
2019-10-3166.72×2019-03-31
2019-11-2992.11×2019-09-30
2019-12-3192.65×2019-09-30
2020-01-3188.62×2019-09-30
2020-02-2838.33×2019-12-31
2020-03-3138.48×2019-12-31
2020-04-3045.65×2019-12-31
2020-05-2955.93×2020-03-31
2020-06-3055.78×2020-03-31
2020-07-3158.12×2020-03-31
2020-08-3144.27×2020-06-30
2020-09-3042.93×2020-06-30
2020-10-3043.74×2020-06-30
2020-11-3052.57×2020-06-30
2020-12-3155.03×2020-06-30
2021-01-2956.31×2020-06-30
2021-02-2662.68×2020-06-30
2021-03-3166.19×2020-06-30
2021-04-3074.09×2020-06-30
2021-05-2871.72×2020-06-30
2021-06-3078.03×2020-06-30
2021-07-3083.58×2020-06-30
2021-08-31145.91×2021-06-30
2021-09-30141.65×2021-06-30
2021-10-29153.07×2021-06-30
2021-11-30110.06×2021-09-30
2021-12-31120.62×2021-09-30
2022-01-3187.76×2021-09-30
2022-02-2882.13×2021-12-31
2022-03-3184.8×2021-12-31
2022-04-2974.35×2021-12-31
2022-05-3167.21×2022-03-31
2022-06-3063.01×2022-03-31
2022-07-2970.03×2022-03-31
2022-08-3149.9×2022-06-30
2022-09-3042.71×2022-06-30
2022-10-3144.56×2022-06-30
2022-11-3047.22×2022-09-30
2022-12-3046.05×2022-09-30
2023-01-3144.26×2022-09-30
2023-02-2844.89×2022-12-31
2023-03-3145.85×2022-12-31
2023-04-2849.36×2022-12-31
2023-05-3148.74×2023-03-31
2023-06-3048.64×2023-03-31
2023-07-3149.7×2023-03-31
2023-08-3146.72×2023-03-31
2023-09-2940.56×2023-03-31
2023-10-3132.55×2023-03-31
2023-11-3037.48×2023-03-31
2023-12-2945.98×2023-03-31
2024-01-3141.9×2023-03-31
2024-02-2943.84×2023-03-31
2024-03-2841.94×2023-03-31
2024-04-3037.67×2023-03-31
2024-05-3146×2023-03-31
2024-06-2842.69×2023-03-31
2024-07-3148.62×2023-03-31
2024-08-3044.09×2023-03-31
2024-09-3047.63×2023-03-31
2024-10-3143.95×2023-03-31
2024-11-2944.9×2023-03-31
2024-12-3142.92×2023-03-31
2025-01-3143.83×2023-03-31
2025-02-2836.8×2023-03-31
2025-03-3134.94×2023-03-31
2025-04-3030×2023-03-31
2025-05-3028.84×2023-03-31
2025-06-3030.66×2023-03-31
2025-07-3132.61×2023-03-31
2025-08-2943.2×2024-03-31
2025-09-3043.99×2024-03-31
2025-10-3149.48×2024-03-31
2025-11-2851.01×2024-03-31
2025-12-3146.5×2024-03-31
2026-01-3050.68×2024-03-31
2026-02-2746.65×2024-03-31
2026-03-3141.32×2024-03-31
2026-04-3043.74×2024-03-31
2026-05-2974.28×2026-03-31
2026-06-30101.54×2026-03-31
2026-07-31103.61×2026-03-31
2026-08-3162.51×2026-06-30
2026-09-2562.77×2026-06-30
Mean 49.96×Median 43.84×43% above median

ROIC

% · Annual / TTM

—
Bio-Techne ROIC. Reported fiscal history.
Fiscal period% · Annual / TTM
FY 2011 Q1—
FY 2011 Q2—
FY 2011 Q3—
FY 2011 Q4—
FY 2012 Q1—
FY 2012 Q2—
FY 2012 Q3—
FY 2012 Q4—
FY 2013 Q1—
FY 2013 Q2—
FY 2013 Q3—
FY 2013 Q4—
FY 2014 Q1—
FY 2014 Q2—
FY 2014 Q3—
FY 2014 Q4—
FY 2015 Q1—
FY 2015 Q2—
FY 2015 Q3—
FY 2015 Q4—
FY 2016 Q1—
FY 2016 Q2—
FY 2016 Q3—
FY 2016 Q4—
FY 2017 Q1—
FY 2017 Q2—
FY 2017 Q3—
FY 2017 Q4—
FY 2018 Q1—
FY 2018 Q2—
FY 2018 Q3—
FY 2018 Q4—
FY 2019 Q1—
FY 2019 Q2—
FY 2019 Q3—
FY 2019 Q4—
FY 2020 Q18.16%
FY 2020 Q2—
FY 2020 Q38.11%
FY 2020 Q48.26%
FY 2021 Q19.15%
FY 2021 Q210.05%
FY 2021 Q312.05%
FY 2021 Q413.53%
FY 2022 Q114.95%
FY 2022 Q215.22%
FY 2022 Q315.8%
FY 2022 Q414.8%
FY 2023 Q1—
FY 2023 Q2—
FY 2023 Q3—
FY 2023 Q4—
FY 2024 Q1—
FY 2024 Q2—
FY 2024 Q3—
FY 2024 Q4—
FY 2025 Q1—
FY 2025 Q2—
FY 2025 Q3—
FY 2025 Q4—
FY 2026 Q1—
FY 2026 Q2—
FY 2026 Q3—
FY 2026 Q4—

Capital allocation

% of tracked cash uses

$62.615M
Bio-Techne capital allocation. Quarterly values. Missing values are unavailable.
PeriodCapexAcquisitionsBuybacksDividendsDebt repaymentsTracked uses
FY 2011 Q18.34% · $1.052MUnavailable15.37% · $1.94M76.29% · $9.629MUnavailable100% · $12.621M
FY 2011 Q26.65% · $0.713MUnavailable0% · $0M93.35% · $10.011MUnavailable100% · $10.724M
FY 2011 Q35.58% · $0.592MUnavailable0% · $0M94.42% · $10.022MUnavailable100% · $10.614M
FY 2011 Q411.26% · $1.273MUnavailable0% · $0M88.74% · $10.029MUnavailable100% · $11.302M
FY 2012 Q15.03% · $1.096MUnavailable48.97% · $10.675M46% · $10.026MUnavailable100% · $21.797M
FY 2012 Q211.21% · $2.201MUnavailable36.02% · $7.073M52.77% · $10.361MUnavailable100% · $19.635M
FY 2012 Q310.28% · $1.587MUnavailable22.89% · $3.535M66.83% · $10.32MUnavailable100% · $15.442M
FY 2012 Q48.23% · $1.133MUnavailable16.83% · $2.315M74.94% · $10.311MUnavailable100% · $13.759M
FY 2013 Q119.61% · $2.515M0% · $0M0% · $0M80.39% · $10.312MUnavailable100% · $12.827M
FY 2013 Q242.66% · $8.22M0% · $0M0% · $0M57.34% · $11.048MUnavailable100% · $19.268M
FY 2013 Q336.57% · $6.373M0% · $0M0% · $0M63.43% · $11.053MUnavailable100% · $17.426M
FY 2013 Q429.35% · $5.346M0% · $0M10% · $1.821M60.66% · $11.05MUnavailable100% · $18.217M
FY 2014 Q13.23% · $3.811M87.4% · $103.049MUnavailable9.37% · $11.051MUnavailable100% · $117.911M
FY 2014 Q224.02% · $3.647M0.66% · $0.1MUnavailable75.32% · $11.434MUnavailable100% · $15.181M
FY 2014 Q327.14% · $4.261M0% · $0MUnavailable72.86% · $11.44MUnavailable100% · $15.701M
FY 2014 Q410.72% · $2.102M30.77% · $6.031MUnavailable58.51% · $11.469MUnavailable100% · $19.602M
FY 2015 Q11.3% · $4.905M95.65% · $360.175MUnavailable3.05% · $11.472MUnavailable100% · $376.552M
FY 2015 Q24.19% · $3.142M79.98% · $59.927MUnavailable15.83% · $11.863MUnavailable100% · $74.932M
FY 2015 Q329.3% · $4.924M0% · $0MUnavailable70.7% · $11.883MUnavailable100% · $16.807M
FY 2015 Q436.84% · $6.934M0% · $0MUnavailable63.16% · $11.888MUnavailable100% · $18.822M
FY 2016 Q16.06% · $6.121M82.16% · $82.97MUnavailable11.78% · $11.894MUnavailable100% · $100.985M
FY 2016 Q229.11% · $4.887MUnavailableUnavailable70.89% · $11.902MUnavailable100% · $16.789M
FY 2016 Q312.47% · $2.836M35.18% · $8MUnavailable52.34% · $11.902MUnavailable100% · $22.738M
FY 2016 Q419.71% · $3.054M3.45% · $0.535MUnavailable76.84% · $11.909MUnavailable100% · $15.498M
FY 2017 Q10.89% · $2.442M94.74% · $259.004MUnavailable4.36% · $11.932MUnavailable100% · $273.378M
FY 2017 Q219.29% · $2.853MUnavailableUnavailable80.71% · $11.939MUnavailable100% · $14.792M
FY 2017 Q325.16% · $4.016MUnavailableUnavailable74.84% · $11.943MUnavailable100% · $15.959M
FY 2017 Q433.76% · $5.868MUnavailableUnavailable66.24% · $11.511MUnavailable100% · $17.379M
FY 2018 Q115.57% · $5.273M31.4% · $10.634MUnavailable35.31% · $11.958M17.72% · $6M100% · $33.865M
FY 2018 Q234.56% · $6.335M0.05% · $0.01MUnavailable65.39% · $11.988MUnavailable100% · $18.333M
FY 2018 Q35.02% · $3.508M77.83% · $54.422MUnavailable17.15% · $11.995MUnavailable100% · $69.925M
FY 2018 Q428.19% · $5.818M13.5% · $2.785MUnavailable58.31% · $12.032MUnavailable100% · $20.635M
FY 2019 Q10.65% · $4.19M42.17% · $272.229MUnavailable1.87% · $12.066M55.32% · $357.125M100% · $645.61M
FY 2019 Q227.49% · $4.604M0.35% · $0.058MUnavailable72.16% · $12.085MUnavailable100% · $16.747M
FY 2019 Q328.95% · $4.925MUnavailable0.01% · $0.001M71.04% · $12.086MUnavailable100% · $17.012M
FY 2019 Q428.5% · $11.692M41.94% · $17.206M0% · $0M29.56% · $12.127MUnavailable100% · $41.025M
FY 2020 Q146.38% · $10.525M0% · $0MUnavailable53.62% · $12.169MUnavailable100% · $22.694M
FY 2020 Q254.42% · $14.564M0% · $0MUnavailable45.58% · $12.196MUnavailable100% · $26.76M
FY 2020 Q312.95% · $9.282M0% · $0M69.92% · $50.112M17.13% · $12.279MUnavailable100% · $71.673M
FY 2020 Q458.63% · $17.373M0% · $0M0% · $0M41.37% · $12.258MUnavailable100% · $29.631M
FY 2021 Q147% · $10.938MUnavailableUnavailable53% · $12.336MUnavailable100% · $23.274M
FY 2021 Q248.01% · $11.445MUnavailableUnavailable51.99% · $12.392MUnavailable100% · $23.837M
FY 2021 Q316.01% · $10.602M0% · $0M65.2% · $43.178M18.79% · $12.446MUnavailable100% · $66.226M
FY 2021 Q44.73% · $11.316M90.07% · $215.587M0% · $0M5.2% · $12.448MUnavailable100% · $239.351M
FY 2022 Q132.7% · $6.07MUnavailableUnavailable67.3% · $12.493MUnavailable100% · $18.563M
FY 2022 Q244.71% · $10.168MUnavailableUnavailable55.29% · $12.576MUnavailable100% · $22.744M
FY 2022 Q317.06% · $15.1MUnavailable68.73% · $60.838M14.21% · $12.577MUnavailable100% · $88.515M
FY 2022 Q415.98% · $13.57MUnavailable69.26% · $58.818M14.76% · $12.539MUnavailable100% · $84.927M
FY 2023 Q16.69% · $9.556M70.83% · $101.184M13.69% · $19.562M8.78% · $12.545MUnavailable100% · $142.847M
FY 2023 Q232.72% · $6.109M0% · $0M0% · $0M67.28% · $12.561MUnavailable100% · $18.67M
FY 2023 Q348.29% · $11.748M0% · $0M0% · $0M51.71% · $12.582MUnavailable100% · $24.33M
FY 2023 Q446.23% · $10.831M0% · $0M0% · $0M53.77% · $12.597MUnavailable100% · $23.428M
FY 2024 Q17.05% · $13.592M86.38% · $166.426MUnavailable6.57% · $12.654MUnavailable100% · $192.672M
FY 2024 Q248.41% · $14.864M10.69% · $3.281MUnavailable40.9% · $12.559MUnavailable100% · $30.704M
FY 2024 Q356.65% · $16.441M0% · $0M0% · $0M43.35% · $12.579MUnavailable100% · $29.02M
FY 2024 Q458.74% · $17.98M0% · $0M0% · $0M41.26% · $12.627MUnavailable100% · $30.607M
FY 2025 Q141.96% · $9.172MUnavailableUnavailable58.04% · $12.688MUnavailable100% · $21.86M
FY 2025 Q234.88% · $6.821MUnavailableUnavailable65.12% · $12.736MUnavailable100% · $19.557M
FY 2025 Q38.25% · $10.123M0% · $0M81.5% · $100.046M10.25% · $12.58MUnavailable100% · $122.749M
FY 2025 Q44.17% · $4.89MUnavailable85.28% · $100.057M10.56% · $12.387MUnavailable100% · $117.334M
FY 2026 Q130.08% · $5.363MUnavailable0.13% · $0.024M69.79% · $12.444MUnavailable100% · $17.831M
FY 2026 Q232.2% · $5.921MUnavailable0% · $0M67.8% · $12.47MUnavailable100% · $18.391M
FY 2026 Q342.06% · $9.086MUnavailable0% · $0M57.94% · $12.518MUnavailable100% · $21.604M
FY 2026 Q413.54% · $8.48MUnavailable66.52% · $41.651M19.94% · $12.484MUnavailable100% · $62.615M

Tracked cash uses · SBC excluded

Sources and calculations

Company filings · USD · Last checked 2026-10-18. Missing inputs remain unavailable. Your chart selection and layout are saved in this browser for Bio-Techne.

All charts share the selected dates. Quarterly/Yearly changes fiscal charts; valuation keeps completed daily closes on a published TTM basis. Later restatements can delay that basis. Historical mean, median and pricing labels use the selected range and do not estimate intrinsic fair value.

SBC deduction is an optional economic-cost scenario for FCF-based metrics. Missing SBC never becomes zero.

Revenue
Reported revenue from company filings.
Free cash flow
Operating cash flow − reported cash capital investment. PPE purchases are preferred; the productive-assets fallback also includes software and intangibles. Reflects the SBC option and can differ from issuer-defined FCF.
Net margin
Reported net income / revenue × 100.
P/E
Completed closing price × diluted shares / TTM earnings attributable to common shareholders.
ROIC
NOPAT / average invested capital × 100. NOPAT = operating income × (1 − effective tax rate). Invested capital = equity including noncontrolling interests + debt − cash and equivalents. Average uses period end and one year earlier.
Capital allocation
Reported cash uses as a percentage of tracked uses. Missing categories remain unavailable; SBC is noncash and excluded.
Reported revenue and sources